Co-morbidities and 90-day Outcomes in Hospitalized COPD Exacerbations

REFERENCES

• Ferrer M, Alonso J, Morera J, Chronic obstructive pulmonary disease stage and health-related quality of life.The Quality of Life Chronic Obstructive Pulmonary Disease Group. Ann Int Med 1997; 127:1072–1079.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J 2008; 32:962–269.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Soriano JB. Chronic Obstructive Pulmonary Disease with Lung cancer and/or Cardiovascular Disease. Proc Am Thorac Soc 2008; 5:842–847.
   PubMedGoogle Scholar
• Barnes PJ, Celli BR. Systemic manifestations and co-morbidities of COPD. Eur Respir J 2009; 33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Terzano C, Conti V, Di Stefano F, Co-morbidity, hospitalization, and mortality in COPD: Results from a longitudinal study. Lung 2010; 188:321–329.
   PubMed Web of Science ®Google Scholar
• Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Int Med 2003; 163:1180–1186.
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2007; 132:1748–1755.
   PubMedGoogle Scholar
• Dewars NA, Rafique S, Kanwar B, Acute exacerbations of COPD factors associated with poor treatment outcome. Chest 2000; 117:662–671.
   PubMed Web of Science ®Google Scholar
• Bustamante-Fermosel A, De Miguel-Yanes JM, Dufort-Falco M, Munoz J. Mortality related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007; 25:515–522.
   PubMed Web of Science ®Google Scholar
• Parappil A, Depczynski B, Collett P, Marks GB. Effect of co-morbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 2010; 15:918–922.
   PubMed Web of Science ®Google Scholar
• Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001; 119:1840–1849.
   PubMed Web of Science ®Google Scholar
• Connors AF, Dawson NV, Thomas C, Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Crit Care Med 1996; 154:959–967.
   Web of Science ®Google Scholar
• Price LC, Lowe D, Anstey K, Hosker HSG, Pearson MG, Roberts CM. The UK national COPD audit 2003. Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006; 61:837–842.
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians of London, British Thoracic Society and British Lung Foundation. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Resources and Organisation of care in Acute NHS units across the UK. http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/ncrop/Pages/Resources.aspx. Date last updated: 21 December 2009. Date last accessed: 16 March 2011.
   Google Scholar
• Royal College of Physicians of London, British Thoracic Society and British Lung Foundation. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: clinical audit of COPD exacerbations admitted to acute NHS units. http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/ncrop/Pages/Resources.aspx. Date last updated: 21 December 2009. Date last accessed: 6 June 2011.
   Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5 year mortality: a randomised clinical trial. Ann Intern Med 2005; 142:233–239.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, TORCH investigators. Salmeterol and fluticasone proprionate and survival in chronic obstructive pulmonary disease. N Eng J Med 2007; 356:775–789.
   PubMed Web of Science ®Google Scholar
• Christensen S, Rasmussen L, Horvath-Puho E, Lenler-Petersen P, Rhode M, Johnsen SP. Arterial blood gas derangement and level of co-morbidity are not predictors of long term mortality of COPD patients treated with mechanical ventilation. Eur J Anesth 2008; 25:550–556.
   PubMed Web of Science ®Google Scholar
• Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbations of COPD: a retrospective study. Chest 2005; 128:518–524.
   PubMed Web of Science ®Google Scholar
• Ranieri P, Bianchetti A, Margiotta A, Virgillo A, Clinic EM, Trabucchi M. Predictors of 6-month mortality in elderly patients with mild Chronic Obstructive Pulmonary Disease discharged from a medical ward after acute nonacidotic exacerbation. J Am Geriatr Soc 2008; 56:909–913.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Martin JM, The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med 2004; 350:10005–10012.
   Google Scholar
• Zielinski J, MacNee W, Wedzicha J Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997; 52:43–47.
   PubMedGoogle Scholar
• Roberts CM, Stone RA, Buckingham RJ, Pursey NA, Lowe D. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax 2011; 66:43–48.
   PubMed Web of Science ®Google Scholar
• Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and co-morbidity predict mortality in COPD patients treated with oxygen therapy. Eur Resp J 2006; 27:689–696.
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, Ochoa de Ehaguen A, Mortality after hospitalization for COPD. Chest 2002;121:1441–1148.
   PubMed Web of Science ®Google Scholar
• Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57:137–141.
   PubMed Web of Science ®Google Scholar
• Connolly MJ, Lowe D, Anstey K, Hosker HSR, Pearson MG, Roberts CM. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 2006; 61:843–848.
   PubMed Web of Science ®Google Scholar
• Barr R, Celli BR, Mannino DM, Co-morbidities, patient knowledge and disease management in a national sample of patients with Chronic Obstructive Pulmonary Disease. Am J Med 2009; 122:348–355.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16:63–70.
   PubMed Web of Science ®Google Scholar
• Cristafulli E, Costi S, Luppi F, Role of co-morbidities in a cohort of patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Thorax 2008; 63:487–492.
   PubMedGoogle Scholar